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===================

*Mycobacterium kansasii* is one of the most significant nontuberculous mycobacterial (NTM) pathogens recovered from clinical specimens and is responsible for a large part of NTM infections in the human population ([@B1], [@B2]). However, culturing of *M. kansasii* from human tissues may not necessarily represent true infection but rather a nonpathogenic colonization. Grouping of *M. kansasii* into seven genetically similar subtypes (I to VII) adds more complexity to the clinical and epidemiological relevance of *M. kansasii* isolations. Of the *M. kansasii* subtypes, type I has been isolated most frequently from human sources and involved in the causation of NTM disease ([@B3][@B4][@B5]).

To better explore the genetic diversity of *M. kansasii* and recognize the effect of genetic background on the bacterial phenotype, the first large-scale *M. kansasii* genome sequencing project has been launched ([@B6]). The project operates on a diverse pool of *M. kansasii* strains, of both environmental and clinical origin, from different geographical locales. The key purpose of the research is to identify molecular markers, specifically those associated with the pathogenic phenotype. This could lead to a new method for a fast and reliable diagnosis of *M. kansasii* disease.

Here, we announce the draft genome sequences of 12 clinical and host-associated *M. kansasii* strains, representing three subtypes---namely, I, II, and VI. The strains were recovered from pulmonary clinic patients in the Netherlands, Germany, and Poland and were sequenced, as summarized in [Table 1](#tab1){ref-type="table"}.

###### 

Genome features and GenBank accession numbers of selected strains

  Strain         Subtype   Source[^a^](#ngtab1.1){ref-type="table-fn"}   Host disease   BioSample no.   Accession no.                                                       Genome size (bp)   Coverage (×)
  -------------- --------- --------------------------------------------- -------------- --------------- ------------------------------------------------------------------- ------------------ --------------
  NLA001000927   I         Sputum                                        NTM disease    SAMN06339040    [CP019883](https://www.ncbi.nlm.nih.gov/nuccore/CP019883)           6,421,275          35
  NLA001001166   VI        Sputum                                        None           SAMN06215600    [MWKW00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWKW00000000)   6,443,486          33
  NLA001001128   II        BAL                                           None           SAMN06339041    [CP019888](https://www.ncbi.nlm.nih.gov/nuccore/CP019888)           6,251,123          46
  NLA001000449   I         Sputum                                        NTM disease    SAMN06339042    [MWKX00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWKX00000000)   6,440,784          39
  NLA001000521   I         BAL                                           NTM disease    SAMN06339043    [CP019884](https://www.ncbi.nlm.nih.gov/nuccore/CP019884)           6,64,9816          44.6
  ATCC 25221     I         Sputum                                        NTM disease    SAMN06339044    [CP019886](https://www.ncbi.nlm.nih.gov/nuccore/CP019886)           6,462,452          36
  B11073207      II        Sputum                                        None           SAMN06339045    [CP019887](https://www.ncbi.nlm.nih.gov/nuccore/CP019887)           6,123,476          34.6
  B11063838      II        BAL                                           None           SAMN06339046    [MWKY00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWKY00000000)   6,126,434          44
  7728           I         BW                                            NTM disease    SAMN06339047    [MWQA00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWQA00000000)   6,463,923          33
  6200           I         Sputum                                        NTM disease    SAMN06339048    [CP019885](https://www.ncbi.nlm.nih.gov/nuccore/CP019885)           6,421,364          39
  7744           I         BW                                            NTM disease    SAMN06339049    [MWKZ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWKZ00000000)   6,434,062          45.8
  2193           II        BW                                            None           SAMN06368474    [MWKV00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWKV00000000)   6,254,980          33

Abbreviations: BAL, bronchoalveolar lavage; BW, bronchial washing.

Genomic DNA was extracted and purified using the protocol of van Embden et al. ([@B7]). Genotyping was performed by means of PCR-restriction endonuclease analysis for the *hsp65* and *tuf* genes, as previously described ([@B4], [@B8]). Illumina paired-end libraries were prepared with the Nextera XT kit, in accordance with the manufacturer's instructions. Whole-genome shotgun sequencing was performed on the MiSeq platform (Illumina) at a read length of 2 × 250 bp.

A total of 1,261,159, 1,274,864, 1,348,130, 1,609,452, 1,549,556, 1,498,034, 1,616,934, 1,386,880, 1,714,844, 1,390,906, 1,207,915, and 1,151,718 reads were obtained for strains NLA001000927, NLA001001166, NLA001001128, NLA001000449, NLA001000521, ATCC 25221, B11073207, B11063838, 7728, 6200, 7744, and 2193, respectively. The draft genomes of genotype I strains were *de novo* assembled with SPAdes software version 3.7.1 ([@B9]), with manual editing using FA_TOOL ([@B10]). The resulting assemblies were scaffolded with MeDuSa software ([@B11]). *De novo* assemblies of genotype II and VI strains were prepared using SPAdes version 3.7.1, Abyss version 2.0.2 ([@B12]), and Ray version 2.3.1 ([@B13]) simultaneously. To improve assembly contiguity, the obtained sets of contigs were integrated using CISA version 1.3 ([@B14]). The scaffolding process was performed by CONTIGuator ([@B15]), while gap closing was done with GapBlaster version 1.1.1 ([@B16]). Annotation was carried out automatically using the NCBI Prokaryotic Genome Annotation Pipeline (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok>). The total lengths of the contigs for each genome, along with some basic clinical data regarding the strains, are presented in [Table 1](#tab1){ref-type="table"}.

Accession number(s). {#s1}
--------------------

The accession numbers of the draft genome sequences of the *M. kansasii* strains reported here are provided in [Table 1](#tab1){ref-type="table"}.
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